Revolution Medicines Inc (NASDAQ: RVMD)’s stock price has decreased by -0.51 compared to its previous closing price of 57.07. However, the company has seen a -1.03% decrease in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-06 that Revolution Medicines, Inc. (RVMD) Q3 2024 Earnings Call Transcript
Is It Worth Investing in Revolution Medicines Inc (NASDAQ: RVMD) Right Now?
Moreover, the 36-month beta value for RVMD is 1.41. Analysts have varying opinions on the stock, with 10 analysts rating it as a “buy,” 8 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for RVMD is 141.01M and currently, short sellers hold a 12.87% of that float. On November 22, 2024, RVMD’s average trading volume was 1.18M shares.
RVMD’s Market Performance
RVMD’s stock has seen a -1.03% decrease for the week, with a 17.05% rise in the past month and a 30.11% gain in the past quarter. The volatility ratio for the week is 4.26%, and the volatility levels for the past 30 days are at 4.25% for Revolution Medicines Inc The simple moving average for the past 20 days is 2.27% for RVMD’s stock, with a 38.53% simple moving average for the past 200 days.
Analysts’ Opinion of RVMD
Many brokerage firms have already submitted their reports for RVMD stocks, with Needham repeating the rating for RVMD by listing it as a “Buy.” The predicted price for RVMD in the upcoming period, according to Needham is $62 based on the research report published on July 16, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $52. The rating they have provided for RVMD stocks is “Overweight” according to the report published on July 12th, 2024.
Jefferies gave a rating of “Buy” to RVMD, setting the target price at $63 in the report published on July 08th of the current year.
RVMD Trading at 12.92% from the 50-Day Moving Average
After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.01% of loss for the given period.
Volatility was left at 4.25%, however, over the last 30 days, the volatility rate increased by 4.26%, as shares surge +20.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +35.29% upper at present.
During the last 5 trading sessions, RVMD fell by -1.03%, which changed the moving average for the period of 200-days by +89.08% in comparison to the 20-day moving average, which settled at $55.52. In addition, Revolution Medicines Inc saw 97.98% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RVMD starting from Cislini Jeff, who sale 2,554 shares at the price of $55.13 back on Nov 15 ’24. After this action, Cislini Jeff now owns 43,080 shares of Revolution Medicines Inc, valued at $140,811 using the latest closing price.
JEFFREY TODD CISLINI, the Officer of Revolution Medicines Inc, proposed sale 2,554 shares at $57.37 during a trade that took place back on Nov 15 ’24, which means that JEFFREY TODD CISLINI is holding shares at $146,523 based on the most recent closing price.
Stock Fundamentals for RVMD
Current profitability levels for the company are sitting at:
- -880.32 for the present operating margin
- -179.13 for the gross margin
The net margin for Revolution Medicines Inc stands at -764.23. The total capital return value is set at -0.4. Equity return is now at value -47.18, with -41.28 for asset returns.
Based on Revolution Medicines Inc (RVMD), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -64.28. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -70.32.
Currently, EBITDA for the company is -430.58 million with net debt to EBITDA at 0.18. When we switch over and look at the enterprise to sales, we see a ratio of 12718.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.24.
Conclusion
To wrap up, the performance of Revolution Medicines Inc (RVMD) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
